A rapid test for the qualitative detection of COVID-19 antigens in nasal swab specimens

A rapid test for the qualitative detection of COVID-19 antigens in nasal swab specimens.

A rapid test for the qualitative detection of COVID-19 antigens in nasal swab specimens.

A rapid test for the qualitative detection of COVID-19 antigens in nasal swab specimens.

A rapid test for the qualitative detection of COVID-19 antigens in nasal swab specimens.

A rapid test for the qualitative detection of COVID-19 antigens in nasal swab specimens.

The Alere™ i Instrument is a portable, fluorescence based instrument intended to be used for the processing and analysis of Alere molecular diagnostic assays.

The Alere™ Reader is a small bench top instrument to be used in conjunction with Alere™ rapid tests.

The ARK Methotrexate Assay c-Pack (cobas c pack green reagent packs) is a homogeneous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on automated clinical chemistry analyzers.

Resorbable Borate Glass Wound Management Device

Resorbable Borate Glass Wound Management Device

4.5mm O.D. x 45-55mm Length

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

LABScreen products are intended for use in detection of HLA antibody using flow cytometric technology

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

For use in determining HLA Class I and Class II cell surface antigens with a complement dependent microlymphocytotoxic technique.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it through the working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it through the working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it through the working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it throughthe working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it through the working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it through the working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) self-expanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it through the working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.

The Zephyr® Endobronchial Valve (Zephyr Valve) is an endobronchial implant designed to occlude airflow in the target lobe and thereby reduce lung volume. The device consists of a one-way silicone duckbill valve attached to a nickel-titanium (Nitinol) selfexpanding retainer that is covered with a silicone membrane. It is implanted in the target bronchus during a bronchoscopy procedure using the Zephyr Endobronchial Delivery Catheter (EDC) that is guided to the targeted bronchus by inserting it throughthe working channel of an adult bronchoscope. Successful lobar occlusion may require placement of multiple Zephyr Valves in bronchi of the target lobe. The Zephyr Valves permit air to vent out of the treated lobe during exhalation but do not permit refilling of this region during inhalation to reduce hyperinflation due to emphysema. Trapped air in the diseased lobe escapes through the Zephyr Valves until the lung volume of the treated lobe is reduced. The Zephyr Valve is designed to be a permanent implant, but can be removed, if necessary.